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Background: Surveillance of infectious diseases is
recognized as the cornerstone of public health decision-
making and practice. The aim of the evaluation of
communicable diseases surveillance systems (CDSS) is
ensuring that communicable diseases are monitored
efﬁciently and effectively. The aim of this paper is to
reﬂect on the experiences of both developed and developing
countries in the evaluation of CDSS in order to learn lessons
from these experiences to improve systems everywhere.
Methods: A literature review of studies published in English
in PubMed and data bases of the World Health Organization
(WHO), and Center of Diseases Control (CDC) from 1981
to 2007 was undertaken assessing CDSS. The studies
were divided into those from developed and developing
countries.
Results: A total of 32 studies were included, 20
from developed and 12 from developing countries. Both
developed and developing countries faced difﬁculties in
CDSS. Studies from the developed countries have been
analyzed based on the quality of the system alone. In
developing countries, most of the studies have been on
the integrated diseases surveillance (IDSR) and have been
performed shortly after the adoption of the IDSR. Thus it
might be too early to make a fair evaluation. Some of the
systems over-centralized, while some lacked private health
sector involvement in the system. Further, some of the
systems were affected by conﬂicts and civil wars which are
common problems in developing countries.
Conclusion: None of the countries had ideal CDSS. The
strategy of integrated diseases surveillance seems to be
functioning well especially in Africa.
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The MIDAS∗ Public Disease Model is an agent based model
(ABM) that uses synthetic data to simulate and describe
inﬂuenza transmission within speciﬁc U.S. geographic areas.
Each person in the region of interest is an agent and each
agent is described by a number of demographic traits that
deﬁne the social network interactions that the agents are
part of. The agent traits that compromise the synthetic
data were developed from US census, National Education
Association and a provider of business information, InfoUSA,
data sources. They represent the U.S. population at the
time of the 2000 Census. The data include:
• A household in every Census tract that corresponds to a
household in the 2000 Census.
• Persons who live in those households within the tracts
such that their important Census tract level demographic
characteristics match those of the 2000 Census.
• Locations of all public and private schools as well as
pre-school and daycare facilities in the US that match a
variety of publicly available sources. Location, enrollment
and grade-level information are also deﬁned.
• An age-speciﬁc school assignment plan that deﬁnes the
schools attended by each school eligible person in the
population.
